ResearcherWest China Hospital of Sichuan UniversityActive in the last 2 years

XunJie Cao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5139608532. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Pan-cancer analysis identifies GPRIN1 as a prognostic biomarker and promoter of cell proliferation in pancreatic cancer. Co-author DOI 10.1016/j.yexmp.2026.105061 ↗
Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer. Co-author DOI 10.3390/cancers18172781 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qing Zhu · 2 shared papers, 2026 · strength 0.79
- Paper Pan-cancer analysis identifies GPRIN1 as a prognostic biomarker and promoter of cell proliferation in pancreatic cancer. DOI 10.1016/j.yexmp.2026.105061 ↗
- Paper Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer. DOI 10.3390/cancers18172781 ↗
Ningna Weng · 1 shared paper, 2026 · strength 0.43
- Paper Pan-cancer analysis identifies GPRIN1 as a prognostic biomarker and promoter of cell proliferation in pancreatic cancer. DOI 10.1016/j.yexmp.2026.105061 ↗
Xingyu He · 1 shared paper, 2026 · strength 0.36
- Paper Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer. DOI 10.3390/cancers18172781 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.